Related Experiment Video
Updated: Feb 13, 2026

An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy
Published on: January 25, 2019
Different lasers and techniques for proliferative diabetic retinopathy.
Tanya Moutray1, Jennifer R Evans, Noemi Lois
1Ophthalmology Department, Royal Victoria Hospital, Grosvenor Road, Belfast, UK, BT12 6BA.
This review found limited evidence on alternative laser treatments for proliferative diabetic retinopathy (PDR). More research is needed to compare new laser modalities and protocols against the standard argon laser photocoagulation for PDR.
Area of Science:
- Ophthalmology
- Medical Technology
- Retinal Diseases
Background:
- Diabetic retinopathy (DR) is a progressive complication of diabetes affecting retinal microvasculature.
- Proliferative DR (PDR) is a severe form of DR that can lead to vision loss.
- Argon laser photocoagulation, guided by the Early Treatment of Diabetic Retinopathy Study (ETDRS), has been the standard PDR treatment.
Purpose of the Study:
- To evaluate the effectiveness and safety of non-argon laser types and modified laser protocols for PDR treatment.
- To compare alternative laser wavelengths, power settings, pulse durations, and burn patterns against standard ETDRS-specified argon laser pan-retinal photocoagulation (PRP).
Main Methods:
- Systematic review of randomized controlled trials (RCTs) comparing alternative laser modalities or protocols to standard argon laser PRP for PDR.
- Searched multiple databases including Cochrane Central Register of Controlled Trials, MEDLINE, Embase, LILACS, ISRCTN, ClinicalTrials.gov, and ICTRP.
- Included studies using GRADE approach for certainty of evidence assessment.
Main Results:
- Eleven studies were included, comparing Nd:YAG or diode lasers, and various argon laser modifications against standard argon laser PRP.
- Evidence for Nd:YAG versus argon laser was of very low certainty for most outcomes.
- Diode laser showed moderate-certainty evidence of being more painful than argon laser, with very low-certainty evidence for other outcomes.
- Several modified argon laser protocols (e.g., different exposure durations, patterns) showed low to very low-certainty evidence for efficacy and safety, often with imprecise estimates.
Conclusions:
- Limited evidence exists regarding the efficacy and safety of alternative laser systems and strategies for PDR compared to standard argon laser photocoagulation.
- Further high-quality research is necessary to establish the benefits of newer laser techniques and protocols in managing PDR.
Related Concept Videos
Proliferative Phase
Notably, the stratum basale, the basal layer of the endometrium, including the basal parts of the uterine glands, remains unaffected by menstruation. Stem cells in this layer undergo mitosis, regenerating the stratum functionalis and thickening the...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Psychoneuroimmunology: Diabetes and Cancer
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational

